Literature DB >> 24521597

Outbreak of Tsukamurella species bloodstream infection among patients at an oncology clinic, West Virginia, 2011-2012.

Isaac See1, Duc B Nguyen, Somu Chatterjee, Thein Shwe, Melissa Scott, Sherif Ibrahim, Heather Moulton-Meissner, Steven McNulty, Judith Noble-Wang, Cindy Price, Kim Schramm, Danae Bixler, Alice Y Guh.   

Abstract

OBJECTIVE: To determine the source and identify control measures of an outbreak of Tsukamurella species bloodstream infections at an outpatient oncology facility.
DESIGN: Epidemiologic investigation of the outbreak with a case-control study.
METHODS: A case was an infection in which Tsukamurella species was isolated from a blood or catheter tip culture during the period January 2011 through June 2012 from a patient of the oncology clinic. Laboratory records of area hospitals and patient charts were reviewed. A case-control study was conducted among clinic patients to identify risk factors for Tsukamurella species bloodstream infection. Clinic staff were interviewed, and infection control practices were assessed.
RESULTS: Fifteen cases of Tsukamurella (Tsukamurella pulmonis or Tsukamurella tyrosinosolvens) bloodstream infection were identified, all in patients with underlying malignancy and indwelling central lines. The median age of case patients was 68 years; 47% were male. The only significant risk factor for infection was receipt of saline flush from the clinic during the period September-October 2011 (P = .03), when the clinic had been preparing saline flush from a common-source bag of saline. Other infection control deficiencies that were identified at the clinic included suboptimal procedures for central line access and preparation of chemotherapy.
CONCLUSION: Although multiple infection control lapses were identified, the outbreak was likely caused by improper preparation of saline flush syringes by the clinic. The outbreak demonstrates that bloodstream infections among oncology patients can result from improper infection control practices and highlights the critical need for increased attention to and oversight of infection control in outpatient oncology settings.

Entities:  

Mesh:

Year:  2014        PMID: 24521597      PMCID: PMC4830385          DOI: 10.1086/675282

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  Diagnosis of venous access port-related infections.

Authors:  M C Douard; G Arlet; P Longuet; C Troje; M Rouveau; D Ponscarme; B Eurin
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Clinical characteristics of infections caused by Tsukamurella spp. and antimicrobial susceptibilities of the isolates.

Authors:  Chia-Ying Liu; Chih-Cheng Lai; Meng-Rui Lee; Yi-Chieh Lee; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2011-10-19       Impact factor: 5.283

3.  Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer.

Authors:  C L Shapiro; R F Haft; N M Gantz; G V Doern; J C Christenson; R O'Brien; J C Overall; B A Brown; R J Wallace
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  A microbiological assay technique for hands.

Authors:  N J Petersen; D E Collins; J H Marshall
Journal:  Health Lab Sci       Date:  1973-01

5.  Hepatitis B outbreak associated with a hematology-oncology office practice in New Jersey, 2009.

Authors:  Rebecca D Greeley; Shereen Semple; Nicola D Thompson; Patricia High; Ellen Rudowski; Elizabeth Handschur; Guo-Liang Xia; Lilia Ganova-Raeva; Jennifer Crawford; Corwin Robertson; Christina Tan; Barbara Montana
Journal:  Am J Infect Control       Date:  2011-06-12       Impact factor: 2.918

6.  An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic.

Authors:  Alexandre Macedo de Oliveira; Kathryn L White; Dennis P Leschinsky; Brady D Beecham; Tara M Vogt; Ronald L Moolenaar; Joseph F Perz; Thomas J Safranek
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

7.  Central venous catheter-related bacteremia due to Tsukamurella species in the immunocompromised host: a case series and review of the literature.

Authors:  M A Schwartz; S R Tabet; A C Collier; C K Wallis; L C Carlson; T T Nguyen; M M Kattar; M B Coyle
Journal:  Clin Infect Dis       Date:  2002-09-10       Impact factor: 9.079

8.  Prevalence of outpatient cancer treatment in the United States: estimates from the Medical Panel Expenditures Survey (MEPS).

Authors:  Michael T Halpern; K Robin Yabroff
Journal:  Cancer Invest       Date:  2008-07       Impact factor: 2.176

9.  Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy.

Authors:  Mark D Gershman; Donald J Kennedy; Judith Noble-Wang; Curi Kim; Jessica Gullion; Marilyn Kacica; Bette Jensen; Neil Pascoe; Lisa Saiman; Jean McHale; Melinda Wilkins; Dianna Schoonmaker-Bopp; Joshua Clayton; Matthew Arduino; Arjun Srinivasan
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

Review 10.  Nosocomial infections in patients with cancer.

Authors:  Mini Kamboj; Kent A Sepkowitz
Journal:  Lancet Oncol       Date:  2009-06       Impact factor: 41.316

View more
  2 in total

Review 1.  Obligate aerobic, gram-positive, weak acid-fast, nonmotile bacilli, Tsukamurella tyrosinosolvens: Minireview of a rare opportunistic pathogen.

Authors:  Daisuke Usuda; Risa Tanaka; Makoto Suzuki; Shintaro Shimozawa; Hayabusa Takano; Yuta Hotchi; Shungo Tokunaga; Ippei Osugi; Risa Katou; Sakurako Ito; Kentaro Mishima; Akihiko Kondo; Keiko Mizuno; Hiroki Takami; Takayuki Komatsu; Jiro Oba; Tomohisa Nomura; Manabu Sugita
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

2.  Tsukamurella pulmonis conjunctivitis in patients with an underlying nasolacrimal duct obstruction - report of two cases.

Authors:  Peter Kechker; Yigal Senderovich; Shifra Ken-Dror; Sivan Laviad-Shitrit; Malka Halpern
Journal:  Access Microbiol       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.